Pharma Journalist -

Chinese Center for Drug Evaluation has sanctioned an expansion of  expansion of the indications for Aggrastat for pharmaceutical company focused on commercializing patent-protected…
Read More...

Clinical-stage, biotherapeutics company, SillaJen committed to the development of oncolytic immunotherapy products for Cancer and ABL Europe company providing dedicated viral vector GMP…
Read More...

Ligand Pharmaceuticals asserted that it has forayed into a worldwide OmniAb platform license agreement with Ferring Pharmaceuticals. As per the terms of the agreement, Ferring…
Read More...

Astellas Pharma confirmed acquisition of MitoBridge. Astellas shelled out $225 million to acquire 100% of the equity in Mitobridge. The acquisition sets the tone for Astellas's further…
Read More...

WCG confirms the appointment of Shannon Bledsoe as its Executive Director. She will be responsible for overall organizational growth and strategic direction and overseeing the quality…
Read More...

Swedish Orphan Biovitrum AB confirmed FDA's acceptance of the investigational new drug application for the drug candidate SOBI003 along with granting Fast track status to it. SOBI003 is…
Read More...

Evofem Biosciences committed to the development and commercialization of women's healthcare products asserted the enrollment of its first patient in  Phase 2b/3 clinical trial…
Read More...

ProMIS Neurosciences committed to the discovery and development of precision treatments for neurodegenerative diseases, announced further results of its previously announced and ongoing…
Read More...

Biomarck Pharmaceuticals affirmed initiation of Phase 2 Clinical study in advanced NSCLC.  The study is meant to compare  standard of Care Therapy alone to SOC plus BIO-11006. BIO-11006…
Read More...

U.S FDA grants clearance for QIAGEN's ipsogen JAK2 RGQ PCR Kit for ascertaining myeloproliferative neoplasms (MPNs), which are a group of cancers in which immature blood cells in the…
Read More...